M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus.
The initiation of hyperinvasive disease in group A Streptococcus (GAS) serotype M1T1 occurs by mutation within the covRS two-component regulon (named covRS for control of virulence regulatory sensor kinase), which promotes resistance to neutrophil-mediated killing through the upregulation of bacteriophage-encoded Sda1 DNase. To determine whether other virulence factors contribute to this phase-switching phenomenon, we studied a panel of 10 isogenic GAS serotype M1T1 virulence gene knockout mutants. While loss of several individual virulence factors did not prevent GAS covRS switching in vivo, we found that M1 protein and hyaluronic acid capsule are indispensable for the switching phenotype, a phenomenon previously attributed uniquely to the Sda1 DNase. We demonstrate that like M1 protein and Sda1, capsule expression enhances survival of GAS serotype M1T1 within neutrophil extracellular traps. Furthermore, capsule shares with M1 protein a role in GAS resistance to human cathelicidin antimicrobial peptide LL-37. We conclude that a quorum of GAS serotype M1T1 virulence genes with cooperative roles in resistance to neutrophil extracellular killing is essential for the switch to a hyperinvasive phenotype in vivo.
Cole
Jason N
JN
Department of Pediatrics, University of California San Diego, La Jolla, California, USA.
Pence
Morgan A
MA
von Köckritz-Blickwede
Maren
M
Hollands
Andrew
A
Gallo
Richard L
RL
Walker
Mark J
MJ
Nizet
Victor
V
D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology*; D016667:Bacterial Capsules / Q000737:chemistry / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics / Q000276:immunology*; D001426:Bacterial Proteins / Q000235:genetics* / Q000276:immunology; D002352:Carrier Proteins / Q000235:genetics / Q000276:immunology*; D005260:Female; D000071677:Histidine Kinase; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism*; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D050296:Microbial Viability; D009154:Mutation; D009504:Neutrophils / Q000276:immunology / Q000382:microbiology; D012097:Repressor Proteins / Q000235:genetics* / Q000276:immunology; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D037521:Virulence Factors / Q000235:genetics / Q000276:immunology
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D002352:Carrier Proteins; C432143:CsrR protein, Streptococcus pyogenes; D047908:Intracellular Signaling Peptides and Proteins; D012097:Repressor Proteins; D037521:Virulence Factors; C014689:streptococcal M protein; D006820:Hyaluronic Acid; C534547:CovS protein, Streptococcus pyogenes; D000071677:Histidine Kinase
EMBO J. 2006 Oct 4;25(19):4628-37
16977314
Cell Microbiol. 2007 May;9(5):1162-71
17217430
Infect Immun. 2005 Oct;73(10):6562-6
16177331
Infect Immun. 2004 Dec;72(12):7107-14
15557634
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15641-6
16223875
J Biol Chem. 2009 Jan 9;284(2):862-71
19001420
Cell Microbiol. 2009 Jan;11(1):138-55
19016794
FASEB J. 2006 Aug;20(10):1745-7
16790522
J Bacteriol. 2005 Oct;187(19):6719-25
16166534
Mol Microbiol. 2000 Jun;36(6):1306-18
10931281
J Innate Immun. 2009;1(3):202-14
20375578
Clin Microbiol Rev. 2000 Jul;13(3):470-511
10885988
J Infect Dis. 2010 Jul 1;202(1):11-9
20507231
J Mol Med (Berl). 2009 Aug;87(8):775-83
19444424
Infect Immun. 1997 Jan;65(1):64-71
8975893
Infect Immun. 1992 Dec;60(12):5036-41
1452335
Nat Rev Microbiol. 2007 Aug;5(8):577-82
17632569
Mol Microbiol. 2005 May;56(3):681-95
15819624
J Bacteriol. 2007 Feb;189(4):1322-9
17114267
Nat Med. 2007 Aug;13(8):981-5
17632528
PLoS Pathog. 2006 Jan;2(1):e5
16446783
J Biol Chem. 1995 Aug 4;270(31):18452-8
7629171
Emerg Infect Dis. 2008 Oct;14(10):1511-7
18826812
Curr Biol. 2006 Feb 21;16(4):396-400
16488874
Infect Immun. 2003 Jan;71(1):446-55
12496195
J Biol Chem. 2006 Mar 24;281(12):8216-23
16431917
Mol Microbiol. 1995 Mar;15(5):907-16
7596292
Science. 2004 Mar 5;303(5663):1532-5
15001782
J Infect Dis. 2001 Apr 1;183(7):1043-54
11237829
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1679-84
15668390
Infect Immun. 2004 May;72(5):2956-63
15102808
Infect Immun. 2000 Nov;68(11):6362-9
11035746
Mol Microbiol. 2004 Jan;51(1):123-34
14651616
Res Microbiol. 1998 Sep;149(8):539-48
9795991
Cell Host Microbe. 2008 Aug 14;4(2):170-8
18692776
Infect Immun. 2007 Dec;75(12):5698-710
17893125
Microbiology (Reading). 2008 Dec;154(Pt 12):3877-3886
19047754
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16755-60
18936485
J Leukoc Biol. 2009 Nov;86(5):1159-69
19638500
J Mol Med (Berl). 2010 Apr;88(4):371-81
19960175
Cell Microbiol. 2006 Apr;8(4):690-703
16548894
J Exp Med. 2003 Oct 6;198(7):1057-68
14517274
Lancet Infect Dis. 2005 Nov;5(11):685-94
16253886
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8317-21
1656437